164
Participants
Start Date
December 31, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
bimatoprost ophthalmic solution 0.01%
One drop of bimatoprost ophthalmic solution 0.01% administered to affected eye(s), once daily in the evening for 12 weeks.
travoprost ophthalmic solution 0.004%
One drop of travoprost ophthalmic solution 0.004% administered to affected eye(s), once daily in the evening for 12 weeks.
latanoprost ophthalmic solution 0.005%
One drop of latanoprost ophthalmic solution 0.005% administered to affected eye(s), once daily in the evening for 12 weeks.
Rogers
Calgary
Lead Sponsor
Allergan
INDUSTRY